Skip to main content
Signal8

SGRY SHAREHOLDER BUYOUT INVESTIGATION: Kaskela Law is Investigating the Proposed Buyout of Surgery Partners, Inc. (SGRY) Shareholders at $23.50 Per Share - Fair Price or Insufficiently Low

$SGRYPress releaseOct 27, 2026, 8:00 AM ETRead the release

Kaskela Law announced an investigation into whether the proposed $23.50-per-share cash buyout of Surgery Partners undervalues shareholders. Surgery Partners agreed on October 26, 2026 to be acquired by HealthSpan Partners, with shareholders cashed out and the stock delisted at closing.

Key figures

Deal Value Usd
0
Buyout price per share
23.5
Analyst price targets mentioned
$28.00+

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.